Last reviewed · How we verify
NCT05906875
A Novel Balance Program to Improve Balance in People With Parkinson's Disease
NA trial testing Lateral Stepping Exercise 1 in Rehabilitation Exercise in 5 participants. Completed in 18 December 2023.
18 December 2023
Quick facts
| Lead sponsor | New York Institute of Technology |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 5 |
| Start date | 20 September 2023 |
| Primary completion | 18 December 2023 |
| Estimated completion | 18 December 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Lateral Stepping Exercise 1
- Lateral Stepping Exercise 2
- Lateral Stepping Exercise 3
- Lateral Stepping Exercise 4
- Lateral Stepping Exercise 5
Conditions studied
- Rehabilitation Exercise — all drugs for Rehabilitation Exercise →
- Physical Therapy — all drugs for Physical Therapy →
Sponsor
New York Institute of Technology
Who can join
Adults 50 to 85, any sex, with Rehabilitation Exercise or Physical Therapy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this exploratory single-blinded feasibility study is to explore the effects of a lateral stepping program integrated into an existing community-based group exercise program for people with PD. The researchers hypothesize that participation in a lateral stepping program a minimum of 2 times/week for 8 weeks, in addition to RSB class participation is feasible in middle to late stage PD and will decrease fall risk factors. The researchers also hypothesize that the integration of this program into an existing community-based RSB program will be deemed feasible as shown by the number of sessions attended by each participant.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05906875
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Rehabilitation Exercise
Currently open trials in the same condition.
- NCT07403331 — Severe Chronic Neuropathic Pain: A Treatment Bundle, Using Spinal Cord Stimulation and Multidisciplinary Treatment, to R · NA · recruiting
- NCT07261553 — Adherence to Home-Based Exercises in Musculoskeletal Disorders · recruiting
- NCT07305389 — The MUSICare Project: Effects of Differentiated Music Exposure on Exercise-Related Affect Among Cardiac Rehabilitation I · NA · recruiting
Other New York Institute of Technology trials
Trials by the same sponsor.
- NCT07341204 — How Virtual Reality Can Help Neurodivergent Children Improve Their Attention · NA · not yet recruiting
- NCT07362329 — Use of Exercise Snacks to Improve Upper Body Fitness · NA · active not recruiting
- NCT07218614 — Can Mobilizations Applied to the Thoracic Spine Improve Oxygen Saturation Levels and Thoracic Kyphosis in E-Cigarette Sm · NA · not yet recruiting
- NCT06671600 — Effects of Osteopathic Manipulative Treatment Protocol on Sleep Quality in Parkinson's Disease Subjects · NA · not yet recruiting
- NCT06546462 — Can a Specific OMT Protocol Influence Patient Pain and Associated Analgesia Use for Primary Headache Disorders? · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05906875 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by New York Institute of Technology
- Last refreshed: 19 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05906875.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing